Prokidney Corp Stock Filter Stocks by Fundamentals
| PROK Stock | USD 2.53 0.19 6.99% |
ProKidney Corp fundamentals help investors to digest information that contributes to ProKidney Corp's financial success or failures. It also enables traders to predict the movement of ProKidney Stock. The fundamental analysis module provides a way to measure ProKidney Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ProKidney Corp stock.
ProKidney | Shares Owned by Insiders |
ProKidney Corp Institutional Holders
Institutional Holdings refers to the ownership stake in ProKidney Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of ProKidney Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ProKidney Corp's value.| Shares | Charles Schwab Investment Management Inc | 2023-12-31 | 255.1 K | Squarepoint Ops Llc | 2023-12-31 | 207.7 K | Nuveen Asset Management, Llc | 2023-12-31 | 135.8 K | Bank Of New York Mellon Corp | 2023-12-31 | 128 K | Renaissance Technologies Corp | 2023-12-31 | 120 K | Federated Hermes Inc | 2023-12-31 | 113.3 K | Goldman Sachs Group Inc | 2023-12-31 | 75.3 K | Xtx Topco Ltd | 2023-12-31 | 73 K | Amundi | 2023-12-31 | 71.8 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 11.2 M | Suvretta Capital Management, Llc | 2023-12-31 | 3.9 M |
ProKidney Fundamentals
| Return On Equity | -0.3 | ||||
| Return On Asset | -0.2 | ||||
| Current Valuation | 1.3 B | ||||
| Shares Outstanding | 61.62 M | ||||
| Shares Owned By Insiders | 22.97 % | ||||
| Shares Owned By Institutions | 60.70 % | ||||
| Number Of Shares Shorted | 13.98 M | ||||
| Price To Book | 91.32 X | ||||
| EBITDA | (148.35 M) | ||||
| Net Income | (35.47 M) | ||||
| Cash And Equivalents | 21.88 M | ||||
| Cash Per Share | 0.36 X | ||||
| Total Debt | 4.41 M | ||||
| Debt To Equity | 5.66 % | ||||
| Current Ratio | 0.74 X | ||||
| Book Value Per Share | (18.43) X | ||||
| Cash Flow From Operations | (90.07 M) | ||||
| Short Ratio | 24.60 X | ||||
| Earnings Per Share | (0.57) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 163 | ||||
| Beta | 1.29 | ||||
| Market Capitalization | 1.82 B | ||||
| Total Asset | 420.55 M | ||||
| Retained Earnings | (1.14 B) | ||||
| Working Capital | 349.11 M | ||||
| Net Asset | 420.55 M |
About ProKidney Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ProKidney Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProKidney Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProKidney Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as ProKidney Corp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out ProKidney Corp Piotroski F Score and ProKidney Corp Altman Z Score analysis. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for ProKidney Stock analysis
When running ProKidney Corp's price analysis, check to measure ProKidney Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProKidney Corp is operating at the current time. Most of ProKidney Corp's value examination focuses on studying past and present price action to predict the probability of ProKidney Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProKidney Corp's price. Additionally, you may evaluate how the addition of ProKidney Corp to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is ProKidney Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.57) | Return On Assets (0.20) | Return On Equity (0.30) |
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.